Dr Chris Nave
Chris is a founding partner and Managing Director of Brandon Capital and Chief Executive Officer of Brandon BioCatalyst. Chris has more than 20 years of experience in venture capital investing into pharmaceutical and medical device companies. Previous roles both locally and internationally in the pharmaceutical, technology transfer and biotechnology industries have seen Chris involved directly […]
Dr John Kurek
John is the Biotechnology Investment Director at Uniseed, Australia’s longest running venture fund, with investment capital provided by nine leading Australian universities, the national science agency CSIRO and leading Australian Superannuation Fund, UniSuper. He is responsible for identifying new investment opportunities from Uniseed partner research organisations and also covers Uniseed’s overall biotechnology and life sciences […]
Prof. Carol Pollock
Professor Carol Pollock is an academic nephrologist with over 310 publications in basic research, largely relating to renal fibrosis and progressive renal disease as well as in clinical trials. Carol is an inaugural Fellow of the Australian Academy of Health and Medical Sciences (2015), was conferred a Vice Chancellors Award for Excellence in Research Supervision […]
Dr Leslie Cousens
Dr Leslie Cousens is Senior Director, GI Search & Evaluation Lead, R&D BD Center for External Innovation, Takeda (Boston/Cambridge, MA). She is an immunologist and seasoned biopharmaceutical leader with a cross-sector career spanning academic immunology research, biotech innovation, and major pharma strategy roles. At Takeda, she leads GI Search & Evaluation within the Center for […]
Mr Thomas Mathers
Tom Mathers joined Certa Therapeutics as Vice Chairman in 2025.